secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acumen Pharmaceuticals, Inc. (ABOS)
CIK:        0001576885
Form:       8-K
Filed at:   2023-07-20T23:59:59+00:00
Accession:  0001193125-23-190489
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acumen Pharmaceuticals prices public offering of 16.8M shares at $7.75/share
----------------------------------------------------------------------------

- Offering of 16,774,193 shares at $7.75 each; underwriters have 30-day option for up to 2,516,128 additional shares.
- Underwriters include BofA Securities, Citigroup Global Markets, and Stifel; closing expected July 21, 2023.
- Estimated offering expenses of ~$440,000 excluding underwriting discounts; proceeds for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576885/000119312523190489/0001193125-23-190489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576885/000119312523190489/d467661d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-190489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer